Commercialisation Agent
Discovery → Revenue · IP Window Optimisation · Direct-to-Patient Architecture
IP Economics D2P Logistics Market Access Supply Chain Trial Strategy
⬡
From Discovery to Revenue,
faster.
This agent works on behalf of scientists and pharma leaders to compress the time between discovery and commercial return — and maximise value within the IP protection window.
IP Window Analysis D2P Revenue Model Regulatory Strategy Supply Chain Cost Market Access
Enter to send · Shift+Enter for new line
controltowers.ai · AI-generated analysis is for strategic guidance only, not regulatory or legal advice